MyAverix Finance
F · Healthcare
BEXIMCO PHARMA.GDR REGS 1 (R2WA)
Drug Manufacturers - Specialty & Generic
BEXIMCO PHARMA.GDR REGS 1 (R2WA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $279.00M, P/E ratio is 4.00, net margin is 13.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R2WA
BEXIMCO PHARMA.GDR REGS 1 (R2WA) — FAQ
What is BEXIMCO PHARMA.GDR REGS 1's market cap?
BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a reported market cap of $279.00M (data as of 2026-03-30).
What is R2WA's P/E ratio?
The price-to-earnings (P/E) ratio for BEXIMCO PHARMA.GDR REGS 1 (R2WA) is 4.00 (data as of 2026-03-30).
Does BEXIMCO PHARMA.GDR REGS 1 pay a dividend?
Dividend yield is not available in the current snapshot for BEXIMCO PHARMA.GDR REGS 1 (R2WA). Check the MyAverix Finance app for the latest dividend data.
What sector is BEXIMCO PHARMA.GDR REGS 1 in?
BEXIMCO PHARMA.GDR REGS 1 (R2WA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is R2WA listed on?
R2WA is listed on F.
What is BEXIMCO PHARMA.GDR REGS 1's net margin?
BEXIMCO PHARMA.GDR REGS 1 (R2WA) reports a net margin of 13.7% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.